and for protein, cytochrome c, or dextran blue, by absorbancy at 280, 407, or 674 nm, respectively, as required .
Results
H-PHAP was capable of precipitating with fetuin in agar gel, whereas L-PHAP lacked this ability when tested against a wide range of fetuin concentrations (Fig .  1) . Within 3-1/2 h, precipitin lines formed between H-PHAP and fetuin at the higher concentrations employed, but these lines had disappeared after a further 17 h of incubation . This phenomenon, reminiscent of the dissolution of antigen-antibody aggregates in the presence of excess antigen, suggested the possibility of the formation of soluble complexes between fetuin and H-PHAP . We therefore undertook a gel chromatographic analysis of the reaction between (15) and also emerged with an apparent mol wt of 110,000 at tube 25 . No alteration in the pattern of fetuin elution could be seen in the presence of 1/400 its weight of either PHAP mitogen. The behavior of H-PHAP was strikingly altered in the presence of fetuin, however, and over 70% of the radioactively labeled material recovered was shifted to an apparent mol wt of 350,000 or greater (tubes [16] [17] [18] . Thus, a minimum estimate of the composition 2 Gel diffusion chromatography has previously been noted to underestimate the true mol wt (136,000) of PHAP isomitogens (2, 13, 14) . of soluble complexes formed between fetuin and H-PHAP would suggest a 2:1 fetuin :H-PHAP molecular ratio; the majority of these complexes were probably larger . Only 5% of the radiolabeled H-PHAP emerged in its normal position, indicating that > 90% H-PHAP was involved in soluble complex formation with fetuin . These estimates are made reasonable by the observation that the total amounts of H-PHAP recovered from the column (fractions 1-40) in the presence of, or absence of fetuin were similar, namely, 86 .5% and 827%, respectively .
The behavior of ["'I ]L-PHAP in the presence of a 400-fold excess of fetuin was quite different. Approximately 7% of the recovered L-PHAP was shifted to a position consonant with a mol wt of >-_290,000 (tubes [16] [17] [18] [19] . The major elution peak emerged at tube 24, a position which is equivalent to a mol wt of approximately 125,000-130,000, indicating that the interaction between L-PHAP and fetuin was very much weaker than that between H-PHAP and fetuin, and was insufficient to sustain even a 1:1 molecular association between the two proteins . Again, the total recovery of L-PHAP in tubes 1-40 was not altered whether or not fetuin was present (74.5zE5 without vs . 78% with fetuin) . Thus H-PHAP is indeed capable of forming soluble complexes with fetuin, whereas the affinity of L-PHAP for fetuin is very much lower and any molecular complexes which form dissociate rapidly .
We have been able to confirm previous observations concerning the ability of fetuin to inhibit H-PHAP-induced lymphocyte transformation (9) ( Table 1) . Despite L-PHAP's much lower affinity for fetuin, the ability of L-PHAP to transform lymphocytes was also markedly inhibited by fetuin at a concentration of 2.5 mg/ml, and to a notable, but significantly less profound degree than for H-PHAP, at a concentration of 1 .25 mg/ml . In agreement with observations by Mendelsohn et al . (9), we have found that fetuin is not nonspecifically toxic to lymphocytes at these concentrations since the amount of DNA synthesis in unstimulated control lymphocytes was not depressed by fetuin, and since the ability of fetuin to depress lymphocyte DNA synthesis in a single lymphocyte preparation at a given fetuin concentration varied with different mitogens (Tables I and 11 ) . In addition, long-term incubation of human lymphocytes in the presence of 2 .5 mg/ml fetuin does not significantly reduce either the number of In each experiment a single preparation of lymphocytes was used in 4-ml cultures . The greater inhibition of lymphocyte transformation by fetuin at 2.5 vs. 1.25 mg/ml for both L-and H-PHAP is highly significant (P values < 0.001 and < 0.01, respectively) . * Used at a concentration of 4 kg/ml. $ Comparison between L-and H-PHAP at each fetuin concentration .
cells remaining in culture nor their viability as measured by trypan-blue exclusion (Table III) . We have also confirmed the capacity of increasing doses of H-PHAP to cause a partial reversal of the inhibitory effects of fetuin on H-PHAP-stimulated lymphocyte transformation (9) . When increasing doses of L-PHAP were employed in a similar fashion, however, a paradoxical effect was noted. Increments in L-PHAP concentration not only failed to overcome the inhibitory effects of fetuin, but led as well to an increase in its inhibitory action (Table IV) . On repeated examinations, this result was most striking at a fetuin concentration of 1.25 mg/ml, where the increase in fetuin inhibition at higher L-PHAP doses achieved a high level of statistical significance (Fig . 3) .
Although we have not made any detailed studies of the physical interaction between CON-A or PWM and fetuin, we have demonstrated that the presence of There is no significant difference in either parameter between control and fetuin-exposed lymphocytes at any fetuin concentration .
fetuin can also inhibit the ability of lymphocytes to synthesize DNA when these mitogens are employed (Table II) . In addition, fetuin proved to be a potent inhibitor of ATS-induced lymphocyte transformation (Table V) as well as of the lymphocyte DNA-synthetic response in the one-way MLC (Table VI) A separate preparation of lymphocytes was employed for each mitogen. In this experiment, a 1-ml culture system containing 1 .5-2 x 10 8 lymphocytes was used .
(1251 ]fetuin were unsuccessful . Fetuin neither binds to, nor is ingested by, lymphocytes to any significant extent, whether the exposure of lymphocytes to fetuin occurs over a short or long period in tissue culture; addition of L-PHAP in optimum mitogenic doses did not alter this result (Table VII) .
Discussion
The evidence for a strong physical interaction between fetuin and H-PHAP is persuasive ; the two proteins can coprecipitate in agar gel, and the dissolution of the precipitates thus formed in the presence of high fetuin :H-PHAP concentration ratios is reflected in the formation of high-mol-wt soluble complexes between fetuin and H-PHAP in free solution at high fetuin :H-PHAP concentration ratios . The gel diffusion experiments would support the conclusion that, in the presence of a large excess of fetuin, each H-PHAP molecule combines with at least two molecules of fetuin, and that some H-PHAP molecules may in fact combine with more than two fetuin molecules . The L-PHAP molecule, on the other hand, shows little, if any affinity for fetuin ; it lacks the ability to form agar gel precipitates with fetuin, and during gel diffusion in the presence of a large fetuin excess only 6-7% of the molecules in L-PHAP are shifted to significantly higher mol wt regions. This figure corresponds closely to an earlier estimate that we have made (8%), on the basis of NH,-terminal amino acid analysis, of the degree to which our L-PHAP preparations are contaminated by R subunits, presumably in the form of the 3L-1R PHAP isomitogen (1) . The low affinity which L-PHAP displays for fetuin is reminiscent of its inability to combine with other serum glycoproteins, and parallels as well its almost total inability to bind to or agglutinate RBC (4) . The L subunit of PHAP isomitogens fails to recognize similar glycopeptide structures on fetuin and RBC membranes, which, however, interact strongly with R subunit-containing PHAP molecules (H-PHAP) (6) . These observations lend reinforcement to previous evidence which suggests that the receptor for PHAP isomitogens on lymphocytes must be different from that on RBC membranes or serum glycoproteins; that the ability of H-PHAP to bind to and transform lymphocytes in a reflection of their hybrid structure; and that such binding and transformation take place predominantly, if not exclusively, through the L subunits of H-PHAP. Thus, with increasing R:L subunit ratios, the H-PHAP isomitogens become increasingly potent as hemagglutinins, but lose their lymphocyte-transforming activity (4) . The 4R H-PHAP isomitogen is almost completely devoid of lymphocyte-transforming ability. 3 Since fetuin can prevent binding of H-PHAP to lymphocytes, and can even reverse a preexisting association between H-PHAP molecules and the lymphocyte membrane (9) , while simultaneously lacking the ability to combine with the L subunits which mediate such binding, it cannot truly be described as a competitive inhibitor of the ability of H-PHAP to attach to lymphocyte membrane receptors. Rather, the presence of large amounts of fetuin would allow for the formation of soluble complexes between fetuin and the H-PHAP molecule, mediated by the strong affinity of the R subunit for the fetuin glycopeptide . The H-PHAP molecules in such complexes may then be unable to bind to lymphocytes through a process of steric hindrance, or possibly through some allosteric conformational change in their L subunit lymphocyte-binding site. The partial removal of previously bound H-PHAP from lymphocyte membranes by the addition of fetuin may simply reflect the fact that the R subunit on hybrid H-PHAP molecules already bound has a higher affinity for the fetuin glycopeptide than their L subunit has for the lymphocyte membrane receptor . After their removal through such a process, reattachment of H-PHAP molecules would be prevented by the mechanisms described above . These processes would adequately explain the inhibition of H-PHAP-induced lymphocyte transformation by fetuin and would also be consistent with the observation that the inhibitory effects of fetuin may be partially overcome by increments in the H-PHAP stimulating dose, since the new equilibrium reached in the competition between fetuin-R subunit and lymphocyte-L subunit associations would result in a greater amount of H-PHAP bound to, and stimulating, lymphocytes.
Since CON-A has also been shown to react strongly with a variety of serum glycoproteins (16) the mechanism by which fetuin inhibits its mitogenic action may resemble that described for H-PHAP . While we can say little about the physical interaction between PWM and fetuin, in the case of L-PHAP it is doubtful that the weak interaction it manifests with fetuin would suffice to account for the ability of the latter to inhibit L-PHAP lymphocyte -mitogenic activity . Although the mitogenic activity of L-PHAP at moderate concentrations (4-5 u, g/ml) is significantly less inhibited by 1.25 mg/ml fetuin than that of H-PHAP, at a fetuin concentration of 2 .5 mg/ml this difference is largely abolished, and cannot be explained by nonspecific toxic effects of fetuin upon the lymphocytes, for reasons which have already been discussed (9) . These observations raise the possibility that fetuin has some direct effect upon the lymphocyte itself which is able to suppress its response to mitogenic stimuli. The paradoxical difference between H-and L-PHAP with respect to the ability of increasing mitogen concentrations to overcome this inhibitory effect of fetuin would also suggest that simple mitogen binding cannot account for the inhibitory, effects of fetuin upon L-PHAP-induced lymphocyte transformation, since these effects would then be expected to parallel those observed with H-PHAP . It is also pertinent to note that the ability of fetuin to inhibit lymphocyte transformation by the two PHAP mitogens is significantly different only at the lowest mitogen dose, and then only at a fetuin concentration of 1 .25 mg/ml. At all other mitogen:fetuin concentration ratios the inhibitory effects of fetuin for L-and H-PHAP are not significantly different . The reversal of fetuin inhibition by increasing H-PHAP concentrations reaches a plateau at 15 .4 Ag/ml; further increase in the H-PHAP dose does . not result in a proportional fall in the inhibitory effects of fetuin . Thus it appears that, in the case of H-PHAP, the inhibitory effects of fetuin may initially depend upon simple competition for mitogen through soluble complex formation; but a second process resembling that seen with L-PHAP may also play a role in preventing transformation . The paradoxical increase in the ability of fetuin to inhibit lymphocyte transformation at higher L-PHAP doses also suggests that the direct inhibitory effect of fetuin on lymphocyte transformation is in some way related to, and dependent upon, the intensity of the mitogenic stimulus .
The experiments with ATS also support the theory that fetuin can directly inhibit the lymphocyte response to mitogens, unless fetuin happened to share an immunologically similar structural determinant with human fetal thymocytes . However, the most compelling evidence for a direct role of fetuin in suppressing lymphocyte responses to mitogenic stimuli comes from a consideration of its effect upon the one-way MLC, where no soluble mitogenic material with a possible independent affinity for the fetuin molecule is involved . In whatever fashion fetuin inhibits the MLC, it does not seem to involve a firm, irreversible association with either the stimulating or responding cell populations, as our experiments with [1211]fetuin demonstrate.
Fetuin is the bovine representative of a class of proteins, the a-fetoproteins, which are present in fetal sera but lacking in homospecific adult sera, and whose role in fetal life is not well understood . The analogous human a-fetoprotein is present in near-maximal concentrations (approximately 200 mg/100 ml) by the 10th wk of gestation. This high serum level is maintained until approximately 22 weeks' gestation and thereafter falls progressively to <5 mg/100 ml near term (17) . One striking property of fetuin is its ability to act as a serum substitute and growth factor for many mammalian cell lines in tissue culture (18) . It has also been reported to stimulate the proliferation of hematopoietic stem cells when injected into mice (19) . Thus it may play a general role as a supporter of, and stimulus for, the high rate of cell proliferation characteristic of fetal development . In this context, its inhibitory effect upon in vitro lymphocyte proliferation may reflect a second highly specialized function in fetal life essential for successful embryonic development, namely, the development of immunologic tolerance to autologous antigens . Its role in this process may rest upon three aspects related to our in vitro observations : (a) Fetuin does not adversely affect resting lymphocyte viability. (b) It is able to inhibit the proliferation of lymphocytes in the presence of a mitogenic stimulus . (c) Its inhibitory effect upon lymphocyte proliferation is proportional to the intensity of the mitogenic stimulus and might conceivably contribute to cell death should the stimulus be strong enough . These premises would allow for the preservation of the repertoire of specificities required of an intact, universally responsive, postnatal immune system, while at the same time suppressing, and possibly aiding in the elimination of, those lymphocyte clones subjected to sustained and intensive provocation by autoantigens in fetal life . Further experiments are in progress to test the validity of these hypotheses .
The capacity of fetuin for inhibiting the proliferative response of lymphocytes to a variety of mitogenic stimuli is reminiscent of the similar effects of another serum a-protein, the immunoregulatory a-globulin (IRA) (20) . Even though IRA also possesses the ability to combine with and precipitate H-PHAP, but not L-PHAP, it is able to suppress lymphocyte transformation by both mitogens approximately to the same degree (21) . A variety of studies has made clear that the immunosuppressive functions of IRA depend upon some direct, but poorly understood effect which it exerts upon the lymphocyte itself (22, 23) , and that it is capable of such diverse actions as the inhibition of the lymphocyte mitogenic response to phytomitogens and antilymphocyte serum, as well as to antigens and to the mixed leukocyte reaction (22) . In addition, IRA inhibits antibody formation and skin graft rejection when it is administered to mice before appropriate challenge (24, 25) . While we do not understand the precise mechanism by which a-glycoproteins such as fetuin or IRA inhibit lymphocyte responsiveness, the special ability which fetuin possesses to perturb the limiting membrane of macrophages and to stimulate pinocytosis may offer a clue (26) , since the initial step in the immune response, or in the activation of lymphocytes by phytomitogens, depends upon the ability of mitogens or antigen to combine with membrane receptors. Derangement of lymphocyte membrane stability, or preventing access to crucial sites on the lymphocyte cell surface early in the course of mitogen action via a "blindfolding" effect (21, 23) , by a substance such as fetuin, may interfere with these initial steps.
Fetuin, the bovine a-fetoprotein, contains glycopeptide sequences similar to those found on red cells . As a result, it is capable of strong physical interaction with the phytohemagglutinin isomitogens (H-PHAP) which possess two or more R (red cell binding) subunits as part of their tetrameric structures . Fetuin shows little or no interaction with L-PHAP, a phytohemagglutinin made up of four L subunits which also lack red cell affinity . Despite these differences fetuin is able to inhibit both H-and L-PHAP-induced lymphocyte transformation and is also capable of inhibiting the mitogenic effects of pokeweed mitogen, concanavalin A, antithymocyte antiserum, and the one-way mixed lymphocyte culture . In the case of L-PHAP, the inhibitory effect of fetuin is proportional to the intensity of the mitogenic stimulus . The inhibitory effects of fetuin upon lymphocyte transformation may result from perturbation or "blindfolding" of the cell membrane in a manner analogous to other immunosuppressive serum aglobulins. a-Fetoproteins may play an immunoregulatory role during fetal development.
